BYD Company Limited - BY6.F

BY6.F Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BY6.F	-2.4	1.3	0.2	-1.9	19.3	39.5	21.6	521.1	893.7	3319.0
S&P 500	0.5	2.1	2.4	5.5	10.1	25.8	38.7	84.0	198.2	34547.3

Compare BY6.F with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BY6.F
name	BYD Company Limited
price	33.29
changes percentage	-2.4326
change	-0.83
day low	33.24
day high	33.59
year high	37.85
year low	20.21
market cap	102674081349
price avg 50	32.5416
price avg 200	29.4259
exchange	XETRA
volume	32341
avg volume	35028
open	33.35
previous close	34.12
eps	1.54
pe	21.62
earnings announcement	2025-03-24T10:59:00.000+0000
shares outstanding	3084231942
timestamp	2025-01-23 20:55:47

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 75.7%

Overall Quarterly Financial Health: 59.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	602315354000	424060635000	42.04
gross profit	121757004000	72244955000	68.53
gross profit ratio	0.2	0.17	18.66
research and development expenses	39574945000	18654453000	112.15
operating expenses	83653909000	49268473000	69.79
interest income	2796195000	1829617000	52.83
interest expense	1827605000	1316350000	38.84
ebitda	82378814000	42684498000	92.99
ebitdaratio	0.14	0.11	29.46
operating income	38103095000	21541819000	76.88
operating income ratio	0.06	0.05	24.53
net income	30040811000	16622448000	80.72
net income ratio	0.05	0.04	27.24
eps	10.32	5.71	80.74

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 602,315 million in 2023 from 424,061 million in 2022 representing a change of 42.04%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 121,757 million in 2023 from 72,245 million in 2022 representing a change of 68.53%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 39,575 million in 2023 from 18,654 million in 2022 representing a change of 112.15%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 82,379 million in 2023 from 42,684 million in 2022 representing a change of 92.99%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 38,103 million in 2023 from 21,542 million in 2022 representing a change of 76.88%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 30,041 million in 2023 from 16,622 million in 2022 representing a change of 80.72%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 10.32 in 2023 from 10.32 in 2022 representing a change of 80.74%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 83,654 million in 2023 from 49,268 million in 2022 representing a change of 69.79%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	201124599000	176182316000	14.16
gross profit	44031018000	32925721000	33.73
gross profit ratio	0.22	0.19	17.14
research and development expenses	13698452000	9010102000	52.03
operating expenses	29607695000	20574826000	43.90
interest income	549397000	597492000	-8.05
interest expense	555478000	535611000	3.71
ebitda	14646849000	12046384000	21.59
ebitdaratio	0.07	0.07	-2.78
operating income	14423323000	11524790000	25.15
operating income ratio	0.07	0.07	9.63
net income	11606858000	9062464000	28.08
net income ratio	0.06	0.05	12.19
eps	3.99	0.4	897.50

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 201,125 million in 2024Q3 from 176,182 million in 2024Q2 representing a change of 14.16%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 44,031 million in 2024Q3 from 32,926 million in 2024Q2 representing a change of 33.73%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 14,647 million in 2024Q3 from 12,046 million in 2024Q2 representing a change of 21.59%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 14,423 million in 2024Q3 from 11,525 million in 2024Q2 representing a change of 25.15%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 3.99 in 2024Q3 from 3.99 in 2024Q2 representing a change of 897.5%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 13,698 million in 2024Q3 from 9,010 million in 2024Q2 representing a change of 52.03%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 29,608 million in 2024Q3 from 20,575 million in 2024Q2 representing a change of 43.9%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 11,607 million in 2024Q3 from 9,062 million in 2024Q2 representing a change of 28.08%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	679547670000	493860646000	37.60
total liabilities	529085557000	372470809000	42.05
total equity	150462113000	121389837000	23.95
cash and cash equivalents	109094408000	51471263000	111.95
short term investments	9562550000	20626930000	-53.64
long term investments	16108319000	1424196000	1031.05
total current assets	302121446000	240803507000	25.46
total non current assets	377426224000	253057139000	49.15
total current liabilities	453666671000	333344561000	36.10
total non current liabilities	75418886000	39126248000	92.76
common stock	2911143000	2911143000	0.00
retained earnings	67123972000	40943232000	63.94
total debt	39145541000	21828796000	79.33

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 679,548 million in 2023 from 493,861 million in 2022 representing a change of 37.6%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 150,462 million in 2023 from 121,390 million in 2022 representing a change of 23.95%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 109,094 million in 2023 from 51,471 million in 2022 representing a change of 111.95%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 302,121 million in 2023 from 240,804 million in 2022 representing a change of 25.46%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 67,124 million in 2023 from 40,943 million in 2022 representing a change of 63.94%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 529,086 million in 2023 from 372,471 million in 2022 representing a change of 42.05%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 9,563 million in 2023 from 20,627 million in 2022 representing a change of -53.64%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 453,667 million in 2023 from 333,345 million in 2022 representing a change of 36.1%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 39,146 million in 2023 from 21,829 million in 2022 representing a change of 79.33%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	764259515000	686244710000	11.37
total liabilities	595456788000	531633632000	12.01
total equity	168802727000	154611078000	9.18
cash and cash equivalents	66319375000	53053301000	25.01
short term investments	25415146000	17388054000	46.16
long term investments	4433472000	10390736000	-57.33
total current assets	362098716000	298431610000	21.33
total non current assets	402160799000	387813100000	3.70
total current liabilities	512091875000	452742803000	13.11
total non current liabilities	83364913000	78890829000	5.67
common stock	2909266000	2909266000	0.00
retained earnings	83349594000	71742986000	16.18
total debt	39615534000	38770481000	2.18

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 764,260 million in 2024Q3 from 686,245 million in 2024Q2 representing a change of 11.37%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 168,803 million in 2024Q3 from 154,611 million in 2024Q2 representing a change of 9.18%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 66,319 million in 2024Q3 from 53,053 million in 2024Q2 representing a change of 25.01%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 25,415 million in 2024Q3 from 17,388 million in 2024Q2 representing a change of 46.16%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 362,099 million in 2024Q3 from 298,432 million in 2024Q2 representing a change of 21.33%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 83,350 million in 2024Q3 from 71,743 million in 2024Q2 representing a change of 16.18%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 595,457 million in 2024Q3 from 531,634 million in 2024Q2 representing a change of 12.01%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 512,092 million in 2024Q3 from 452,743 million in 2024Q2 representing a change of 13.11%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 39,616 million in 2024Q3 from 38,770 million in 2024Q2 representing a change of 2.18%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	57329288000	1362597000	4107.35
operating cash flow	169725025000	140837657000	20.51
free cash flow	47631516000	43380795000	9.80
capital expenditure	-122093509000	-97456862000	-25.28
depreciation and amortization	43280077000	20285924000	113.35
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	-7602102000	-36564504000	79.21
acquisitions net	-13881312000	95800000	-14589.89
investments in property plant and equipment	-122093509000	-97456862000	-25.28
net cash used for investing activites	-125663644000	-120595997000	-4.20
debt repayment	18073144000	-16412946000	210.12
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-3974320000	-1553388000	-155.85
net cash used provided by financing activities	12817127000	-19488683000	165.77
cash at end of period	108511745000	51182457000	112.01
accounts receivables	-12641191000	0	NaN
cash at beginning of period	51182457000	49819860000	2.74

Overall Score of Annual Cashflow Statement

0.83 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 57,329 million in 2023 from 1,363 million in 2022 representing a change of 4107.35%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 169,725 million in 2023 from 140,838 million in 2022 representing a change of 20.51%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 47,632 million in 2023 from 43,381 million in 2022 representing a change of 9.8%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -122,094 million in 2023 from -97,457 million in 2022 representing a change of -25.28%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -12,641 million in 2023 from 0 million in 2022 representing a change of nan%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Dividends Paid: Dividends Paid decreased to -3,974 million in 2023 from -1,553 million in 2022 representing a change of -155.85%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	0	NaN
free cash flow	-22291986000	-21131312000	-5.49
capital expenditure	-22291986000	-21131312000	-5.49
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	2487000	0	NaN
investments in property plant and equipment	-22291986000	-21131312000	-5.49
net cash used for investing activites	-30776473000	-28604477000	-7.59
debt repayment	10684592000	-5994362000	278.24
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-9245325000	-101576000	-9001.88
net cash used provided by financing activities	396971000	-7174881000	105.53
net change in cash	11583089000	-31952176000	136.25
cash at end of period	65809661000	54226572000	21.36
cash at beginning of period	54226572000	86178748000	-37.08

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 11,583 million in 2024Q3 from -31,952 million in 2024Q2 representing a change of 136.25%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -22,292 million in 2024Q3 from -21,131 million in 2024Q2 representing a change of -5.49%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Free Cash Flow: Free Cash Flow decreased to -22,292 million in 2024Q3 from -21,131 million in 2024Q2 representing a change of -5.49%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid decreased to -9,245 million in 2024Q3 from -102 million in 2024Q2 representing a change of -9001.88%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	207.24	145.67	42.27
net income per share	10.34	5.71	81.02
operating cash flow per share	58.4	48.38	20.71
free cash flow per share	16.39	14.9	9.98
cash per share	40.83	24.77	64.84
book value per share	51.77	41.7	24.15
tangible book value per share	37.25	33.12	12.46
shareholders equity per share	47.76	38.14	25.22
interest debt per share	16.81	7.95	111.38
market cap	559773025200	748068382029.01	-25.17
enterprise value	497564649200	718425915029.01	-30.74
pe ratio	18.63	45.0	-58.59
price to sales ratio	0.93	1.76	-47.32
pocfratio	3.3	5.31	-37.91
pfcf ratio	11.75	17.24	-31.85
pb ratio	4.03	6.74	-40.15
ptb ratio	4.03	6.74	-40.15
ev to sales	0.83	1.69	-51.24
enterprise value over ebitda	6.1	16.49	-62.98
ev to operating cash flow	2.93	5.1	-42.53
ev to free cash flow	10.45	16.56	-36.92
earnings yield	0.05	0.02	141.52
free cash flow yield	0.09	0.06	46.73
debt to equity	0.34	0.2	71.80
debt to assets	0.07	0.04	56.10
net debt to ebitda	-0.76	-0.68	-12.17
current ratio	0.67	0.72	-7.81
interest coverage	19.44	16.36	18.79
income quality	5.41	7.95	-31.90
dividend yield	0.01	0.0	1637.56
payout ratio	0.13	0.02	619.44
sales general and administrative to revenue	0.0	0.0	43.78
research and ddevelopement to revenue	0.07	0.04	49.36
intangibles to total assets	0.06	0.05	22.82
capex to operating cash flow	0.72	0.69	3.96
capex to revenue	0.2	0.23	-11.80
capex to depreciation	2.8	4.8	-41.65
stock based compensation to revenue	0.0	0.0	31.69
graham number	105.39	70.0	50.56
roic	0.13	0.13	-1.93
return on tangible assets	0.05	0.04	32.96
graham net net	-108.04	-72.78	-48.46
working capital	-151545225000	-92541054000	-63.76
tangible asset value	108257281000	96417426000	12.28
net current asset value	-226964111000	-131667302000	-72.38
invested capital	165968579000	112070988000	48.09
average receivables	67683519000	59997615500	12.81
average payables	169460220500	106798738500	58.67
average inventory	83391973500	61230990500	36.19
days sales outstanding	42.47	56.18	-24.40
days payables outstanding	150.05	145.7	2.99
days of inventory on hand	66.28	82.07	-19.24
receivables turnover	8.59	6.5	32.28
payables turnover	2.43	2.51	-2.90
inventory turnover	5.51	4.45	23.82
roe	0.22	0.15	44.56
capex per share	42.01	33.48	25.48

• Positive

  ROE: Return on Equity (ROE) increased to 0.22 on 2023-12-31 from 0.15 on 2022-12-31, representing a change of 44.56%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 18.63 on 2023-12-31 from 45.00 on 2022-12-31, representing a change of -58.59%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.67 on 2023-12-31 from 0.72 on 2022-12-31, representing a change of -7.81%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.34 on 2023-12-31 from 0.20 on 2022-12-31, representing a change of 71.80%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
BY6.F
calendar year	2024	2024	NaN
revenue per share	69.22	59.55	16.24
net income per share	3.99	3.12	28.08
operating cash flow per share	14.66	1.44	916.91
free cash flow per share	6.82	-5.83	216.87
cash per share	31.57	24.85	27.05
book value per share	58.1	53.21	9.18
tangible book value per share	43.68	38.92	12.22
shareholders equity per share	53.51	49.15	8.88
interest debt per share	13.83	14.31	-3.35
market cap	892860974888.78	717054728458.4	24.52
enterprise value	866157133888.78	705031296458.4	22.85
pe ratio	19.23	19.78	-2.78
price to sales ratio	4.44	4.14	7.12
pocfratio	20.97	171.24	-87.76
pfcf ratio	45.09	-42.32	206.54
pb ratio	5.74	5.02	14.37
ptb ratio	5.74	5.02	14.37
ev to sales	4.31	4.07	5.69
enterprise value over ebitda	59.14	60.83	-2.79
ev to operating cash flow	20.34	168.37	-87.92
ev to free cash flow	43.74	-41.61	205.12
earnings yield	0.01	0.01	2.86
free cash flow yield	0.02	-0.02	193.86
debt to equity	0.25	0.29	-11.32
debt to assets	0.05	0.06	-13.30
net debt to ebitda	-1.82	-1.04	-75.74
current ratio	0.71	0.66	7.27
interest coverage	25.97	14.88	74.47
income quality	3.67	0.46	693.99
dividend yield	0.01	0.0	7209.70
payout ratio	0.8	0.01	7006.61
sales general and administrative to revenue	0.06	0.02	156.67
research and ddevelopement to revenue	0.07	0.05	30.80
intangibles to total assets	0.05	0.06	-9.40
capex to operating cash flow	0.52	5.05	-89.63
capex to revenue	0.11	0.12	-9.24
capex to depreciation	0	0.67	-100.00
stock based compensation to revenue	0	0.0	-100.00
graham number	69.35	58.73	18.09
roic	0.05	0.03	78.83
return on tangible assets	0.02	0.01	14.31
graham net net	-122.72	-117.95	-4.05
working capital	-149993159000	-154311193000	2.80
tangible asset value	126899143000	113081104000	12.22
net current asset value	-233358072000	-233202022000	-0.07
invested capital	182529170000	170693380000	6.93
average receivables	96905694500	75454010500	28.43
average payables	225118328000	204609869500	10.02
average inventory	118555830500	105765949500	12.09
days sales outstanding	50.7	41.87	21.09
days payables outstanding	137.76	131.79	4.53
days of inventory on hand	71.25	70.84	0.58
receivables turnover	1.78	2.15	-17.42
payables turnover	0.65	0.68	-4.33
inventory turnover	1.26	1.27	-0.57
roe	0.07	0.06	17.63
capex per share	7.67	7.27	5.49

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 19.23 on 2024-09-30 Q3 from 19.78 on 2024-06-30 Q2, representing a change of -2.78%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 0.71 on 2024-09-30 Q3 from 0.66 on 2024-06-30 Q2, representing a change of 7.27%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.25 on 2024-09-30 Q3 from 0.29 on 2024-06-30 Q2, representing a change of -11.32%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None